The use of intravenous gamma-globulin for prevention of sepsis in pre-term infants. A controlled clinical trial.
This paper reports a randomized clinical trial to study the effect of an intravenous gamma-globulin preparation to prevent sepsis in pre-term newborn infants. 80 infants were enrolled: 37 of birthweight less than or equal to 1500 g and 43 of birthweight 1501-2000 g. In each group 20 infants received an intravenous preparation of gamma-globulin (0.5 g/kg/wk); the remaining 17 and 20, respectively, served as control cases. No significant differences in the occurrence of sepsis were observed between the group receiving prophylactively intravenous gamma-globulin and the control group. This is particularly evident in infants under intensive care (35% of the total population): in this group 2/3 of sepsis occurred in infants who received IgG. Among the infants with sepsis, the presence of an umbilical artery catheterization represented a significant risk-factor. The post-dose increment of serum IgG did not differ significantly in infants with and without sepsis; the post-dose serum disappearance rate in concentration appears identical in the two groups.
Didato
M A
MA
Institute of Social and Preventive Pediatrics, University of Palermo, Italy.
Gioeli
R
R
Priolisi
A
A
D002986:Clinical Trials as Topic; D006801:Humans; D007116:Immunization, Passive / Q000379:methods*; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000032:analysis; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000276:immunology / Q000517:prevention & control*; D007262:Infusions, Intravenous; D011897:Random Allocation; D018805:Sepsis / Q000276:immunology / Q000517:prevention & control*
D007074:Immunoglobulin G